Canadian AIDS Treatment Information Exchange
click here to return to catie main menu
DonateNow

Curry for cancer?

TreatmentUpdate 104 - 2000 January; Volume 11 Issue 10
Hosein SR click here for french language version of article

B-cells are immune system cells that produce antibodies, which are proteins that help fight against certain infections. The abnormal growth of B-cells can lead to some types of cancer in people with HIV/AIDS. One such cancer is non-Hodgkin's lymphoma, an aggressive tumour that may not respond well to therapy, particularly if it's located in the brain or has spread to several locations. Doctors are conducting experiments with cocktails of anti-cancer drugs to improve the quality of life and survival rates of people with lymphoma.

Curcumin, which is responsible for the yellow colour in curry, has anti-inflammatory activity. Researchers in Kentucky and South Korea have found that it has potential as a treatment for lymphoma.

Study details

Researchers conducted laboratory experiments on B- and T-cells as well as on several types of B-cell lymphomas.

Results

Suppressing the immune system

In light of these results, the researchers believe that, when taken in large doses, curcumin may be as powerful an immune-suppressant as the drug cyclosporin. Cyclosporin is given to organ transplant recipients to help prevent their immune systems from rejecting new organs. Given its potential to suppress the immune system, curcumin should be used with caution by people with HIV/AIDS.

Curcumin and T-cell suicide

Exactly how curcumin affects T-cell function is not clear from these experiments. Curcumin causes lymphoma cells to undergo apoptosis. It would be troubling if curcumin also triggered this process in T-cells.

Curcumin may have limited use as an anti-lymphoma agent. Perhaps tests in SIV-infected monkeys could establish whether or not high-dose curcumin should be tested in humans with lymphoma. The intestine does not absorb curcumin well, so people may take it with the drug piperine, an extract of black pepper that boosts absorption of curcumin when given to mice and humans.

REFERENCES

1. Han S-S, Chung S-T, Robertson DA, et al. Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregularion of egr-1, C-myc, Bcl-XL, NF-kB, and p53. Clinical Immunology 1999;93(2):152-161.

2. Dockrell DH, Badley AD, Algeciras-Schimnich A, et al. Activation-induced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy number. AIDS Research and Human Retroviruses 1999;15(17):1509-1518.

3. Jobin C, Bradham CA, Russo MP, et al. Curcumin blocks cytokine-mediated NF-kB activation proinflammatory gene expression by inhibiting inhibitory factor I-kB kinase activity. Journal of Immunology 1999;163:3474-3483.

4. Shoba G, Joy D, Joseph T, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica 1998;64(4):353-356.

20000101
CATE10408


ÆGIS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 2000 - TreatmentUpdate. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Editor, The Canadian AIDS Treatment Information Exchange, 555 Richmond St. West, Suite 505, Box 1104, Toronto, ON, M5V 3B1 • Phone: 416-203-7122 • Toll Free: 1-800-263-1638 • Fax: 416-203-8284  http://www.catie.ca


Disclaimer: The editors have taken all such care as they consider reasonable in preparing this database, but they cannot be held responsible for any inaccuracies or mis-statements of fact contained herein. Inclusion in this database of any information on any treatment, therapy, or clinical trial in no way represents an endorsement of that treatment, therapy, or trial by ÆGiS or any of its sponsors. This data should always be used in conjunction with professional medical advice.
©1986,2000. ÆGiS.